Company / Accounts Receivable
Guardant Health, Inc. Accounts Receivable History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Accounts Receivable
$137.8M
FY2025
5-year range
$88.8M / $137.8M
FY2021-FY2025
Trend
+25.0%
vs FY2024
Sector context
#88 of 143
Health Care
What the data says
At $138M, Guardant Health, Inc.'s accounts receivable ranks #88 of 143 in the Health Care sector. Improved from $89M to $138M over the past 2 years.
Based on SEC 10-K filings.
$138M in FY2025 with a 5-year CAGR of +20.9%.
Improved from $89M to $138M over the past 2 years.
Health Care sector context is included.
Accounts Receivable over time
Growth rates
- 3-Year CAGR
- +12.3%
- 5-Year CAGR
- +20.9%
- 10-Year CAGR
- -
Sector benchmark
#88 of 143 in Health CareTop 62% of 143This company $137.8M Sector average $1.3B
▼
-89.6% below sector average
Key checks
Key Insights
- 5-year CAGR of +20.9%, indicating consistent growth.
- In FY2025, accounts receivable increased 25.0% year-over-year.
- Ranks #88 out of 143 companies in the Health Care sector.
- Lowest accounts receivable in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score -1.05 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Accounts ReceivableValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $137.8M | +25.0% |
| FY2024 | $110.3M | +24.2% |
| FY2023 | $88.8M | -8.7% |
| FY2022 | $97.3M | -0.4% |
| FY2021 | $97.7M | +83.2% |
| FY2020 | $53.3M | +11.1% |
| FY2019 | $48.0M | +34.5% |
| FY2018 | $35.7M | +179.1% |
| FY2017 | $12.8M | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026